再鼎醫藥有限公司 - 存託憑證（普通股）
US ˙ NasdaqGM ˙ US98887Q1040

SecurityZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
InstitutionInvesco Ltd.
Latest Disclosed Ownership82,310,360 shares
Ownership 8.40%
Invesco Ltd. ownership in ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)

2023-02-10 - Invesco Ltd. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 82,310,360 shares of Zai Lab Limited - Depositary Receipt (Common Stock) (US:ZLAB). This represents 8.4 percent ownership of the company. In their previous filing dated 2022-02-14 , Invesco Ltd. had reported owning 7,286,493 shares, indicating an increase of 1,029.63 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2023-02-10 2023-02-10 13G/A 7,286,493 82,310,360 1,029.63 8.40 10.53
2022-02-14 2022-02-14 13G 7,286,493 7.60

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ZAI LAB ADR 98887Q104 26,558 -4,036 -13.19 500 -7.42 0.0000
2026-02-19 2025-12-31 13F ZAI LAB ADR 98887Q104 30,594 -7,960 -20.65 540 -58.73 0.0001
2025-11-13 2025-09-30 13F ZAI LAB ADR 98887Q104 38,554 -9,045 -19.00 1,307 -21.51 0.0002
2025-08-13 2025-06-30 13F ZAI LAB ADR 98887Q104 47,599 -6,945 -12.73 1,665 -15.58 0.0003
2025-05-12 2025-03-31 13F ZAI LAB ADR 98887Q104 54,544 10,204 23.01 1,971 69.77 0.0004
2025-02-13 2024-12-31 13F ZAI LAB ADR 98887Q104 44,340 1,790 4.21 1,161 13.05 0.0002
2024-11-12 2024-09-30 13F ZAI LAB ADR 98887Q104 42,550 -1,456 -3.31 1,027 34.78 0.0002
2024-08-13 2024-06-30 13F ZAI LAB ADR 98887Q104 44,006 -1,337 -2.95 763 4.96 0.0002
2024-05-14 2024-03-31 13F ZAI LAB ADR 98887Q104 45,343 -1,848,186 -97.61 726 -98.60 0.0002
2024-02-13 2023-12-31 13F ZAI LAB ADR 98887Q104 1,893,529 -1,315,774 -41.00 51,750 -33.67 0.0123
2023-11-13 2023-09-30 13F ZAI LAB ADR 98887Q104 3,209,303 -403,158 -11.16 78,018 -22.12 0.0210
2023-08-11 2023-06-30 13F ZAI LAB ADR 98887Q104 3,612,461 -1,190,165 -24.78 100,174 -37.29 0.0263
2023-05-12 2023-03-31 13F ZAI LAB ADR 98887Q104 4,802,626 -3,428,410 -41.65 159,735 -36.79 0.0446
2023-02-13 2022-12-31 13F ZAI LAB ADR 98887Q104 8,231,036 -95,093 -1.14 252,693 -11.26 0.0740
2022-11-14 2022-09-30 13F ZAI LAB ADR 98887Q104 8,326,129 49,696 0.60 284,754 -0.79 0.0917
2022-08-15 2022-06-30 13F ZAI LAB ADR 98887Q104 8,276,433 18,315 0.22 287,027 -20.97 0.0870
2022-05-16 2022-03-31 13F ZAI LAB ADR 98887Q104 8,258,118 1,006,575 13.88 363,192 -20.31 0.0926
2022-02-14 2021-12-31 13F ZAI LAB ADR 98887Q104 7,251,543 2,552,103 54.31 455,759 -7.98 0.1099
2021-11-15 2021-09-30 13F ZAI LAB ADR 98887Q104 4,699,440 3,285,522 232.37 495,274 97.91 0.1255
2021-08-17 2021-06-30 13F ZAI LAB ADR 98887Q104 1,413,918 1,286,327 1,008.16 250,250 1,369.98 0.0615
2021-05-17 2021-03-31 13F ZAI LAB ADR 98887Q104 127,591 -17,311 -11.95 17,024 -13.19 0.0045
2021-02-16 2020-12-31 13F ZAI LAB ADR 98887Q104 144,902 13,365 10.16 19,611 79.26 0.0057
2020-11-16 2020-09-30 13F ZAI LAB ADR 98887Q104 131,537 21,760 19.82 10,940 21.34 0.0037
2020-08-14 2020-06-30 13F ZAI LAB ADR 98887Q104 109,777 78,408 249.95 9,016 458.27 0.0032
2020-05-15 2020-03-31 13F ZAI LAB ADR 98887Q104 31,369 -16,783 -34.85 1,615 -19.37 0.0007
2020-02-14 2019-12-31 13F ZAI LAB ADR 98887Q104 48,152 658 1.39 2,003 30.40 0.0006
2019-11-14 2019-09-30 13F ZAI LAB ADR 98887Q104 47,494 10,242 27.49 1,536 18.24 0.0004
2019-08-14 2019-06-30 13F/A-1 ZAI LAB ADR 98887Q104 37,252 -1,468 -3.79 1,299 13.65 0.0003
2019-08-14 2019-06-30 13F ZAI LAB ADR 98887Q104 37,252 -1,468 1,299
2019-05-15 2019-03-31 13F ZAI LAB ADR 98887Q104 38,720 149 0.39 1,143 27.57 0.0004
2019-02-14 2018-12-31 13F ZAI LAB ADR 98887Q104 38,571 15,069 64.12 896 95.63 0.0003
2018-11-14 2018-09-30 13F ZAI LAB ADR 98887Q104 23,502 8,945 61.45 458 35.50 0.0001
2018-08-14 2018-06-30 13F ZAI LAB ADR 98887Q104 14,557 -3,458 -19.20 338 -12.21 0.0001
2018-05-15 2018-03-31 13F ZAI LAB ADR 98887Q104 18,015 18,015 385 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.